Search
Becton Dickinson and Co
BDXAdd to Watchlist
180.940USD
-0.440-0.24%
Close 09-18 16:00（ET）
49.26BMarket Cap
45.56P/E TTM
After-hours 19:00 (ET)180.940USD+0.350+0.19%
After-hours 19:00 (ET)Becton Dickinson and Co (BDX) Revenue Performance
Updated: Jun 30, 2026Last year, Becton Dickinson and Co generated 4.58B USD for its biggest-performing segment, Medication Delivery Solutions. The United States made the largest contribution, accounting for 12.79B USD last year. For the latest quarter, Becton Dickinson and Co reported the revenue of 1.16B USD for the period ending 2026-06-30, which came from the top-performing segment, Medication Delivery Solutions. United States contributed the highest revenue, at 3.08B USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Medication Delivery Solutions
Medication Management Solutions
Pharmaceutical Systems
Peripheral Intervention
Specimen Management
Integrated Diagnostic Solutions
Urology and Critical Care
Surgery
Biosciences
Advanced Patient Monitoring
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Medication Delivery Solutions
4.58B(20.95%)
4.43B(21.88%)
4.29B(22.16%)
4.31B(22.83%)
4.10B(21.44%)
3.60B(22.37%)
Medication Management Solutions
3.47B(15.91%)
3.30B(16.29%)
2.98B(15.38%)
2.53B(13.42%)
2.43B(12.71%)
2.45B(15.27%)
Pharmaceutical Systems
2.32B(10.64%)
2.27B(11.23%)
2.23B(11.51%)
2.00B(10.60%)
1.83B(9.56%)
1.59B(9.87%)
Peripheral Intervention
2.00B(9.14%)
1.93B(9.55%)
1.86B(9.63%)
1.76B(9.32%)
1.71B(8.94%)
1.51B(9.40%)
Specimen Management
1.87B(8.57%)
--(--)
--(--)
--(--)
--(--)
--(--)
Integrated Diagnostic Solutions
1.84B(8.42%)
3.68B(18.17%)
3.62B(18.71%)
4.18B(22.18%)
5.22B(27.31%)
3.53B(21.97%)
Urology and Critical Care
1.65B(7.55%)
1.55B(7.68%)
1.37B(7.09%)
1.30B(6.92%)
1.23B(6.44%)
1.13B(7.03%)
Surgery
1.57B(7.20%)
1.49B(7.37%)
1.50B(7.73%)
1.40B(7.42%)
1.30B(6.77%)
1.12B(6.97%)
Biosciences
1.46B(6.68%)
1.51B(7.47%)
1.51B(7.79%)
1.38B(7.31%)
1.30B(6.82%)
1.14B(7.11%)
Advanced Patient Monitoring
1.08B(4.95%)
74.00M(0.37%)
--(--)
--(--)
--(--)
--(--)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
International
Europe
Greater Asia
Other
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
United States
12.79B(58.56%)
11.66B(57.80%)
11.11B(57.36%)
10.72B(56.82%)
10.37B(54.21%)
9.16B(57.00%)
9.73B(56.27%)
International
9.05B(41.44%)
8.52B(42.20%)
8.26B(42.64%)
8.15B(43.18%)
8.76B(45.79%)
6.91B(43.00%)
--(--)
Europe
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
3.36B(19.43%)
Greater Asia
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
2.73B(15.77%)
Other
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
1.48B(8.54%)